14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $136.19 $156.84 Thursday, 25th Apr 2024 ASND stock ended at $136.93. This is 4.37% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.23% from a day low at $136.19 to a day high of $140.59.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Sep 22, 2021 $158.45 $160.17 $156.89 $157.72 80 433
Sep 21, 2021 $158.24 $160.95 $156.06 $158.45 72 311
Sep 20, 2021 $158.23 $162.26 $155.67 $157.61 85 336
Sep 17, 2021 $158.97 $163.21 $158.20 $161.51 295 266
Sep 16, 2021 $157.32 $159.42 $154.43 $159.22 118 129
Sep 15, 2021 $153.56 $157.33 $152.00 $157.32 142 375
Sep 14, 2021 $156.00 $159.51 $152.99 $153.54 268 671
Sep 13, 2021 $156.29 $160.22 $152.25 $157.40 99 482
Sep 10, 2021 $158.46 $159.94 $153.67 $154.44 266 533
Sep 09, 2021 $159.09 $162.46 $157.20 $158.46 132 311
Sep 08, 2021 $161.10 $165.66 $158.60 $161.00 120 160
Sep 07, 2021 $164.27 $167.51 $161.06 $164.11 252 629
Sep 03, 2021 $178.71 $178.71 $165.61 $167.00 427 465
Sep 02, 2021 $169.59 $177.84 $167.50 $176.92 620 238
Sep 01, 2021 $155.66 $166.45 $154.00 $165.72 506 227
Aug 31, 2021 $154.28 $158.30 $154.28 $156.73 227 090
Aug 30, 2021 $159.65 $159.65 $150.56 $154.28 267 325
Aug 27, 2021 $151.00 $157.49 $150.45 $154.76 419 295
Aug 26, 2021 $150.57 $158.78 $146.09 $149.70 2 228 445
Aug 25, 2021 $121.90 $124.40 $119.62 $123.67 205 912
Aug 24, 2021 $122.79 $122.79 $119.57 $121.75 250 544
Aug 23, 2021 $120.71 $122.71 $120.50 $122.00 228 331
Aug 20, 2021 $119.21 $122.54 $119.21 $120.45 159 027
Aug 19, 2021 $118.39 $120.16 $117.04 $119.08 147 643
Aug 18, 2021 $121.63 $121.92 $119.01 $119.56 145 656
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT